On 5 May 2026, Alzheimer Europe was pleased to welcome representatives of its corporate sponsors to a Company Round Table meeting in Brussels (Belgium), together with Alzheimer Europe staff. The meeting was chaired by Jean Georges, Executive Director.
Cindy Birck, Project Officer, presented some recent clinical trial developments and gave an update on our Clinical Trials Watch service. She was followed by Lukas Duffner, Project Officer, who discussed our work to support research participation and data sharing, including our recent data sharing report. Up next was a presentation on regulatory and HTA challenges for new anti-amyloid treatments, given by Stéphane Epelbaum, International Leader Neuroscience, Eli Lilly. Ana Diaz, Public Involvement Lead was next, with an overview of our Public Involvement activities, and Jean Georges closed out the meeting, sharing some updates on AE’s Annual Conference and other activities, meetings and projects in 2026.
